Cargando…
Mendelian randomization reveals no associations of genetically-predicted obstructive sleep apnea with the risk of type 2 diabetes, nonalcoholic fatty liver disease, and coronary heart disease
BACKGROUND: Obstructive sleep apnea (OSA) has been reported to affect cardiometabolic diseases. However, whether such association is causal is still unknown. Here, we attempt to explore the effect of OSA on type 2 diabetes (T2D), nonalcoholic fatty liver disease (NAFLD) and coronary heart disease (C...
Autores principales: | Ding, Xiaoxu, Zhao, Lanqing, Cui, Xiangguo, Qi, Li, Chen, Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9949721/ https://www.ncbi.nlm.nih.gov/pubmed/36846222 http://dx.doi.org/10.3389/fpsyt.2023.1068756 |
Ejemplares similares
-
The impact of obstructive sleep apnea on nonalcoholic fatty liver disease
por: Tang, Haiying, et al.
Publicado: (2023) -
Nonalcoholic fatty liver disease is associated with the development of obstructive sleep apnea
por: Chung, Goh Eun, et al.
Publicado: (2021) -
The association between glycometabolism and nonalcoholic fatty liver disease in patients with obstructive sleep apnea
por: Ding, Haibo, et al.
Publicado: (2018) -
The Different Facets of Heart Rate Variability in Obstructive Sleep Apnea
por: Qin, Hua, et al.
Publicado: (2021) -
Fibromax-based nonalcoholic fatty liver disease in chronic obstructive pulmonary disease patients with obstructive sleep apnea: Methodological considerations
por: Monneret, Denis
Publicado: (2017)